News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Jones Lang LaSalle (JLL) had its price target raised by UBS Group AG from $425.00 to $445.00. They now have a "buy" rating on the stock.

Life sciences lab real estate is clawing back from disaster. Here's what that means for investors Share [CNBC]

JLL Wins Tampa Logistics Hub Mandate As Shares Trade Below Targets [Yahoo! Finance]

Hines Secures $55.75M for Prime Oxnard Multifamily Real Estate [Los Angeles Times (CA)]

The power has swung back to employers—and workers are paying for it in benefits, flexibility, and leverage [Yahoo! Finance]

2/18/2026

07:30 am

JLL

8.4%

BEAT

11/5/2025

07:30 am

JLL

-1.5%

BEAT

8/6/2025

07:30 am

JLL

3.9%

BEAT

5/7/2025

07:30 am

JLL

-1.4%

BEAT

Form ARS JONES LANG LASALLE INC For: Dec 31

Form DEF 14A JONES LANG LASALLE INC For: May 28

Form DEFA14A JONES LANG LASALLE INC

Form 4 JONES LANG LASALLE INC For: Apr 09 Filed by: Ulbrich Christian

Form 4 JONES LANG LASALLE INC For: Apr 08 Filed by: Shah Mihir

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}